anisomycin and Carcinoma--Embryonal

anisomycin has been researched along with Carcinoma--Embryonal* in 1 studies

Other Studies

1 other study(ies) available for anisomycin and Carcinoma--Embryonal

ArticleYear
c-Jun amino-terminal kinase is regulated by Galpha12/Galpha13 and obligate for differentiation of P19 embryonal carcinoma cells by retinoic acid.
    The Journal of biological chemistry, 1997, Sep-26, Volume: 272, Issue:39

    Retinoic acid induces P19 mouse embryonal carcinoma cells to differentiate to endoderm and increases expression of the heterotrimeric G-protein subunits Galpha12 and Galpha13. Retinoic acid was found to induce differentiation and sustained activation of c-Jun amino-terminal kinase, but not of ERK1,2 or of p38 mitogen-activated protein kinases. Much like retinoic acid, expression of constitutively active forms of Galpha12 and Galpha13 induced differentiation and constitutive activation of c-Jun amino-terminal kinase. Expression of the dominant negative form of c-Jun amino-terminal kinase 1 blocked both the activation of c-Jun amino-terminal kinase and the induction of endodermal differentiation in the presence of retinoic acid. These data implicate c-Jun amino-terminal kinase as a downstream element of activation of Galpha12 or Galpha13 obligate for retinoic acid-induced differentiation.

    Topics: Animals; Anisomycin; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Embryonal; Cell Differentiation; Embryonic and Fetal Development; Enzyme Activation; GTP-Binding Proteins; JNK Mitogen-Activated Protein Kinases; Lewis X Antigen; Mice; Mitogen-Activated Protein Kinases; Tretinoin

1997